Larisa Strom
Impact in
- Virology top 10%
- HIV Research and Treatment
- Infectious Diseases top 10%
- Viral Infections and Outbreaks Research
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
- Virology 5
- HIV Research and Treatment 4
-
- COVID-19 Clinical Research Studies 4
- Viral Infections and Outbreaks Research 3
- Journals
- The Lancet Infectious Diseases (3 papers)Nature Medicine (2 papers)npj Vaccines (2 papers)JCI Insight (2 papers)JAMA Network Open (1 paper)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Larisa Strom
19 papers receiving 573 citations
Larisa Strom's Hit Papers
Peers
Comparison fields: 5 of 53
- Virology 37
- Infectious Diseases 146
- Public Health, Environmental and Occupational Health 149
- Epidemiology 108
- Biomaterials 38
Countries citing papers authored by Larisa Strom
This map shows the geographic impact of Larisa Strom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larisa Strom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larisa Strom more than expected).
Fields of papers citing papers by Larisa Strom
This network shows the impact of papers produced by Larisa Strom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larisa Strom. The network helps show where Larisa Strom may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial Hit paper breakdown → | 2022 | 135 |
| 2 | 2022 | 91 | |
| 3 | 2023 | 73 | |
| 4 | 2021 | 56 | |
| 5 | 2023 | 50 | |
| 6 | 2022 | 31 | |
| 7 | 2022 | 30 | |
| 8 | 2023 | 30 | |
| 9 | 2023 | 19 | |
| 10 | 2024 | 15 | |
| 11 | 2022 | 14 | |
| 12 | 2022 | 10 | |
| 13 | 2024 | 10 | |
| 14 | 2022 | 9 | |
| 15 | 2025 | 5 | |
| 16 | 2024 | 4 | |
| 17 | 2022 | 1 | |
| 18 | 2025 | 1 | |
| 19 | 2026 | 1 |
About Larisa Strom
Larisa Strom is a scholar working on Virology, Infectious Diseases, Epidemiology, Public Health, Environmental and Occupational Health and Nephrology, having authored 19 papers that have together received 585 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (4 papers), HIV Research and Treatment (4 papers), Influenza Virus Research Studies (3 papers), Viral Infections and Outbreaks Research (3 papers), Malaria Research and Control (2 papers), Virology and Viral Diseases (1 paper), Acute Kidney Injury Research (1 paper) and Acute Myeloid Leukemia Research (1 paper). The work is most often cited by research in Virology (37 citations), Infectious Diseases (146 citations), Public Health, Environmental and Occupational Health (149 citations), Epidemiology (108 citations) and Biomaterials (38 citations). Larisa Strom has collaborated with scholars based in United States, France and United Kingdom. Their work appears in journals such as The Lancet Infectious Diseases, Nature Medicine, npj Vaccines, JCI Insight and JAMA Network Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.